- Home
- LILA vs YDES Comparison
LILA vs YDES Comparison
Compare LILA & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILA
- YDES
- Stock Information
- Founded
- LILA 2017
- YDES 2013
- Country
- LILA Bermuda
- YDES Taiwan
- Employees
- LILA N/A
- YDES N/A
- Industry
- LILA Cable & Other Pay Television Services
- YDES
- Sector
- LILA Telecommunications
- YDES
- Exchange
- LILA Nasdaq
- YDES Nasdaq
- Market Cap
- LILA 1.3B
- YDES 1.1B
- IPO Year
- LILA N/A
- YDES N/A
- Fundamental
- Price
- LILA $8.21
- YDES $18.00
- Analyst Decision
- LILA Sell
- YDES
- Analyst Count
- LILA 1
- YDES 0
- Target Price
- LILA $6.50
- YDES N/A
- AVG Volume (30 Days)
- LILA 230.7K
- YDES 103.6K
- Earning Date
- LILA 11-05-2025
- YDES 09-30-2025
- Dividend Yield
- LILA N/A
- YDES N/A
- EPS Growth
- LILA N/A
- YDES N/A
- EPS
- LILA N/A
- YDES N/A
- Revenue
- LILA $4,409,700,000.00
- YDES $510,360.00
- Revenue This Year
- LILA $1.37
- YDES N/A
- Revenue Next Year
- LILA N/A
- YDES N/A
- P/E Ratio
- LILA N/A
- YDES N/A
- Revenue Growth
- LILA N/A
- YDES 45.76
- 52 Week Low
- LILA $4.26
- YDES $5.30
- 52 Week High
- LILA $10.79
- YDES $25.00
- Technical
- Relative Strength Index (RSI)
- LILA 56.09
- YDES N/A
- Support Level
- LILA $8.09
- YDES N/A
- Resistance Level
- LILA $8.49
- YDES N/A
- Average True Range (ATR)
- LILA 0.22
- YDES 0.00
- MACD
- LILA -0.01
- YDES 0.00
- Stochastic Oscillator
- LILA 50.00
- YDES 0.00
About LILA Liberty Latin America Ltd.
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.